These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Train-of-four: to use or not to use. Tschida SJ; Hoey LL; Mather D; Vance-Bryan K Pharmacotherapy; 1995; 15(4):546-50. PubMed ID: 7479212 [TBL] [Abstract][Full Text] [Related]
24. [Molecular theory about the mechanism of action of curare compounds]. Waser PG Anaesthesist; 1971 Jan; 20(1):23-9. PubMed ID: 4251063 [No Abstract] [Full Text] [Related]
25. [Mechanism of action of muscle relaxants and its clinical problems]. Suzuki H Masui; 1974 Aug; 23(8):679-92. PubMed ID: 4372420 [No Abstract] [Full Text] [Related]
26. [Competitive antagonism between pancuronium and acetylcholine]. Corrado AP; de Morais IP; Prado WA Rev Bras Anestesiol; 1972; 22(1):2-9. PubMed ID: 4261780 [No Abstract] [Full Text] [Related]
27. [Mechanism of action of muscle relaxants]. Nishimura N; Yoshino M Masui; 1971 Feb; 20(2):160-5. PubMed ID: 4251038 [No Abstract] [Full Text] [Related]
28. [The importance of neuromuscular monitoring during anesthesia for neuroradiologic diagnosis]. Schönstedt R; Böhrer H Anaesthesiol Reanim; 1993; 18(2):53-6. PubMed ID: 8397672 [TBL] [Abstract][Full Text] [Related]
29. [On the interaction of combinations of nondepolarizing neuromuscular blocking drugs (author's transl)]. Schuh FT Anaesthesist; 1981 Nov; 30(11):537-42. PubMed ID: 6459041 [TBL] [Abstract][Full Text] [Related]
30. [Results of the association of depolarizing and non-depolarizing muscle relaxants]. Foldes FF Anesth Analg (Paris); 1971; 28(5):859-69. PubMed ID: 4258297 [No Abstract] [Full Text] [Related]
31. Impaired neuromuscular transmission after recovery of the train-of-four ratio. Eikermann M; Gerwig M; Hasselmann C; Fiedler G; Peters J Acta Anaesthesiol Scand; 2007 Feb; 51(2):226-34. PubMed ID: 17261149 [TBL] [Abstract][Full Text] [Related]
32. Sevoflurane increases fade of neuromuscular response to TOF stimulation following rocuronium administration in children. A PK/PD analysis. Woloszczuk-Gebicka B; Wyska E; Grabowski T Paediatr Anaesth; 2007 Jul; 17(7):637-46. PubMed ID: 17564645 [TBL] [Abstract][Full Text] [Related]
33. Affinity of curare-like compounds and their potency in blocking neuromuscular transmission. Lu TC J Pharmacol Exp Ther; 1970 Sep; 174(3):560-6. PubMed ID: 4247938 [No Abstract] [Full Text] [Related]
34. Sugammadex: a novel agent for the reversal of neuromuscular blockade. Nicholson WT; Sprung J; Jankowski CJ Pharmacotherapy; 2007 Aug; 27(8):1181-8. PubMed ID: 17655516 [TBL] [Abstract][Full Text] [Related]
35. [A nondepolarizing muscle relaxant with rapidly developing and short-term action]. Danilov AF; Zhabko EP Eksp Klin Farmakol; 1998; 61(5):18-20. PubMed ID: 9854626 [TBL] [Abstract][Full Text] [Related]
36. [Considerations on presynaptic neuromuscular transmission and block]. Foldes FF Rev Bras Anestesiol; 1971; 21(3):277-95. PubMed ID: 4333102 [No Abstract] [Full Text] [Related]
37. [Effects of melatonin on muscle contractility and neuromuscular blockade produced by muscle relaxants]. Uchida K; Aoki T; Satoh H; Tajiri O Masui; 1997 Feb; 46(2):205-12. PubMed ID: 9071104 [TBL] [Abstract][Full Text] [Related]
38. Neuromuscular transmission and its pharmacological blockade. Part 1: Neuromuscular transmission and general aspects of its blockade. Booij LH Pharm World Sci; 1997 Feb; 19(1):1-12. PubMed ID: 9089749 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of muscle acetylcholine receptors by nondepolarizing drugs: humans are not unique. Dilger JP; Steinbach JH Anesthesiology; 2010 Jan; 112(1):247-9; author reply 249-50. PubMed ID: 20032711 [No Abstract] [Full Text] [Related]